Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Alector (NASDAQ:ALEC) through any online brokerage.
Other companies in Alector’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Alector has a consensus price target of $5.21.
The stock price for Alector (NASDAQ: ALEC) is $1.81 last updated October 7, 2026 at 6:32 AM EDT.
There are no upcoming dividends for Alector.
Alector does not have any upcoming earnings scheduled.
There is no upcoming split for Alector.
Alector is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.